Utah Medical Products, Inc. (NASDAQ:UTMD) Holdings Increased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC grew its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 127.0% during the first quarter, Holdings Channel reports. The institutional investor owned 13,086 shares of the medical instruments supplier’s stock after acquiring an additional 7,320 shares during the period. Los Angeles Capital Management LLC’s holdings in Utah Medical Products were worth $931,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UTMD. FMR LLC raised its position in shares of Utah Medical Products by 2.0% during the 3rd quarter. FMR LLC now owns 389,831 shares of the medical instruments supplier’s stock worth $33,525,000 after buying an additional 7,738 shares in the last quarter. Natixis Advisors L.P. acquired a new stake in Utah Medical Products during the third quarter valued at approximately $1,102,000. Quadrature Capital Ltd lifted its stake in Utah Medical Products by 128.3% during the third quarter. Quadrature Capital Ltd now owns 13,363 shares of the medical instruments supplier’s stock valued at $1,156,000 after purchasing an additional 7,510 shares during the last quarter. Everett Harris & Co. CA lifted its stake in Utah Medical Products by 3.6% during the fourth quarter. Everett Harris & Co. CA now owns 14,828 shares of the medical instruments supplier’s stock valued at $1,249,000 after purchasing an additional 517 shares during the last quarter. Finally, Clean Yield Group lifted its stake in Utah Medical Products by 1.6% during the fourth quarter. Clean Yield Group now owns 31,748 shares of the medical instruments supplier’s stock valued at $2,674,000 after purchasing an additional 485 shares during the last quarter. 69.60% of the stock is currently owned by institutional investors.

Utah Medical Products Price Performance

UTMD stock opened at $66.57 on Tuesday. Utah Medical Products, Inc. has a 12 month low of $65.91 and a 12 month high of $99.46. The firm has a market cap of $234.99 million, a PE ratio of 14.79 and a beta of 0.14. The firm has a 50 day simple moving average of $67.78 and a 200 day simple moving average of $73.12.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, April 25th. The medical instruments supplier reported $1.09 EPS for the quarter. The business had revenue of $11.34 million during the quarter. Utah Medical Products had a net margin of 33.40% and a return on equity of 13.06%.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 5th. Investors of record on Friday, June 14th will be given a $0.30 dividend. The ex-dividend date is Friday, June 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. Utah Medical Products’s dividend payout ratio (DPR) is presently 26.67%.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.